Ytel Announces The Addition of Major Pharmaceutical Client
Ytel has been selected by a major pharmaceutical company to provide branded caller ID, call remediation, and global cloud contact center services.
LAKE FOREST, Calif., Jan. 23, 2023 /PRNewswire-PRWeb/ -- Ytel, a leading provider of cloud-based communication solutions, announced today that it has been selected by a major pharmaceutical company to provide branded caller ID, call remediation, and global cloud contact center services.
The $200B+ pharmaceutical company, which is a leader in the industry, will be utilizing Ytel's platform to enhance its customer experience and communication efforts. The platform will provide the company with the ability to personalize the caller ID of its representatives, ensuring that customers recognize and trust the caller before answering the phone. Additionally, Ytel's call remediation services will improve call quality and increase the chances of connecting with customers. The company will be utilizing Ytel's Cloud Contact Center to provide agents with reliable connectivity in North America, Europe, and Asia.
"We are thrilled to be working with such a respected and innovative pharmaceutical company," said Nick Newsom, CEO of Ytel. "Our platform will help the company to improve communication with its customers, which is critical in the highly regulated pharmaceutical industry."
The partnership between Ytel and the pharmaceutical company is set to begin immediately and will continue for an undisclosed period of time.
About Ytel
Founded in 2012, Ytel helps brands improve their answer rates. Ytel's webphone, cloud contact center, and programmable APIs allow businesses to have trusted communications through calls and text messages. As a cloud-based enterprise carrier, Ytel improves the quality of all your communications without compromising security.
Media Contact
Matt Bos, Ytel, 1 9496728276, [email protected]
SOURCE Ytel
Share this article